J. G. Albeck, J. M. Burke, S. L. Spencer, D. A. Lauffenburger, and P. K. Sorger, Modeling a Snap-Action, Variable-Delay Switch Controlling Extrinsic Cell Death, PLoS Biol, vol.6, 2008.

B. B. Aldridge, S. Gaudet, D. A. Lauffenburger, and P. K. Sorger, Lyapunov exponents and phase diagrams reveal multi-factorial control over TRAIL-induced apoptosis, Mol. Syst. Biol, vol.7, 2011.

V. Almendro, A. Marusyk, and K. Polyak, Cellular Heterogeneity and Molecular Evolution in Cancer, Annu. Rev. Pathol. Mech. Dis, vol.8, pp.277-302, 2013.

A. Ashkenazi, R. C. Pai, S. Fong, S. Leung, D. A. Lawrence et al., Safety and antitumor activity of recombinant soluble Apo2 ligand, J. Clin. Invest, vol.104, pp.155-162, 1999.

K. Azijli, S. Yuvaraj, M. P. Peppelenbosch, T. Wurdinger, H. Dekker et al., Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3-dependent invasion in resistant non-small cell lung cancer cells, J. Cell Sci, vol.125, pp.4651-4661, 2012.

E. Z. Bagci, Y. Vodovotz, T. R. Billiar, G. B. Ermentrout, and I. Bahar, Bistability in Apoptosis: Roles of Bax, Bcl-2, and Mitochondrial Permeability Transition Pores, Biophys. J, vol.90, pp.1546-1559, 2006.

G. Balázsi, A. Van-oudenaarden, and J. J. Collins, Cellular Decision Making and Biological Noise: From Microbes to Mammals, Cell, vol.144, pp.910-925, 2011.

R. Ballweg, A. L. Paek, and T. Zhang, A dynamical framework for complex fractional killing, 2017.

A. Becker, L. Crombag, D. A. Heideman, F. B. Thunnissen, A. W. Van-wijk et al., Retreatment with erlotinib: Regain of TKI sensitivity following a drug holiday for patients with NSCLC who initially responded to EGFR-TKI treatment, Eur. J. Cancer, vol.47, pp.2603-2606, 2011.

M. Bentele, I. Lavrik, M. Ulrich, S. Stößer, D. W. Heermann et al., Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis, J. Cell Biol, vol.166, pp.839-851, 2004.

F. Bertaux, S. Stoma, D. Drasdo, and G. Batt, Modeling Dynamics of Cell-to-Cell Variability in TRAIL-Induced Apoptosis Explains Fractional Killing and Predicts Reversible Resistance, PLoS Comput. Biol, vol.10, 2014.
URL : https://hal.archives-ouvertes.fr/hal-00942885

P. D. Bhola and A. Letai, Mitochondria-Judges and Executioners of Cell Death Sentences, Mol. Cell, vol.61, pp.695-704, 2016.

P. D. Bhola and S. M. Simon, Determinism and divergence of apoptosis susceptibility in mammalian cells, J. Cell Sci, vol.122, pp.4296-4302, 2009.

M. R. Birtwistle, A. Von-kriegsheim, K. Kida, J. P. Schwarz, K. I. Anderson et al., Linear Approaches to Intramolecular Förster Resonance Energy Transfer Probe Measurements for Quantitative Modeling, PLoS ONE, vol.6, 2011.

W. J. Blake, G. Balázsi, M. A. Kohanski, F. J. Isaacs, K. F. Murphy et al., Phenotypic Consequences of Promoter-Mediated Transcriptional Noise, Mol. Cell, vol.24, pp.853-865, 2006.

W. J. Blake, M. Kaern, C. R. Cantor, and J. J. Collins, Noise in eukaryotic gene expression, Nature, vol.422, pp.633-637, 2003.

Z. Bódi, Z. Farkas, D. Nevozhay, D. Kalapis, V. Lázár et al., Phenotypic heterogeneity promotes adaptive evolution, PLOS Biol, vol.15, 2017.

M. Bouhaddou, A. M. Barrette, A. D. Stern, R. J. Koch, M. S. Distefano et al., A mechanistic pancancer pathway model informed by multi-omics data interprets stochastic cell fate responses to drugs and mitogens, PLOS Comput. Biol, vol.14, 2018.

D. Brenner and T. W. Mak, Mitochondrial cell death effectors, Curr. Opin. Cell Biol, vol.21, pp.871-877, 2009.

A. Brock, H. Chang, and S. Huang, Non-genetic heterogeneity -a mutation-independent driving force for the somatic evolution of tumours, Nat. Rev. Genet, vol.10, pp.336-342, 2009.

J. M. Brown and L. D. Attardi, The role of apoptosis in cancer development and treatment response, Nat. Rev. Cancer, vol.5, pp.231-237, 2005.

W. Brune and C. Andoniou, Die Another Day: Inhibition of Cell Death Pathways by Cytomegalovirus, vol.9, p.249, 2017.

J. H. Buchbinder, D. Pischel, K. Sundmacher, R. J. Flassig, and I. N. Lavrik, Quantitative single cell analysis uncovers the life/death decision in CD95 network, PLOS Comput. Biol, vol.14, 2018.

L. Calzone, L. Tournier, S. Fourquet, D. Thieffry, B. Zhivotovsky et al., Mathematical Modelling of Cell-Fate Decision in Response to Death Receptor Engagement, PLoS Comput. Biol, vol.6, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00704979

S. Casagranda, S. Touzeau, D. Ropers, and J. Gouzé, Principal process analysis of biological models, BMC Syst. Biol, vol.12, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01818033

J. R. Chabot, J. M. Pedraza, P. Luitel, and A. Van-oudenaarden, Stochastic gene expression out-of-steady-state in the cyanobacterial circadian clock, Nature, vol.450, pp.1249-1252, 2007.

F. K. Chan and .. , A Domain in TNF Receptors That Mediates Ligand-Independent Receptor Assembly and Signaling, Science, vol.288, pp.2351-2354, 2000.

P. M. Chaudhary, M. Eby, A. Jasmin, A. Bookwalter, J. Murray et al., Death Receptor 5, a New Member of the TNFR Family, and DR4 Induce FADD-Dependent Apoptosis and Activate the NF-?B Pathway, Immunity, vol.7, pp.821-830, 1997.

M. Chaves, T. Eissing, and F. Allgöwer, Regulation of Apoptosis via the NF?B Pathway: Modeling and Analysis, Dynamics On and Of Complex Networks, pp.19-33, 2009.

C. Chen, J. Cui, H. Lu, R. Wang, S. Zhang et al., Modeling of the Role of a Bax-Activation Switch in the Mitochondrial Apoptosis Decision, Biophys. J, vol.92, pp.4304-4315, 2007.

C. Chen, J. Cui, W. Zhang, and P. Shen, Robustness analysis identifies the plausible model of the Bcl-2 apoptotic switch, FEBS Lett, vol.581, pp.5143-5150, 2007.

J. E. Chipuk, T. Moldoveanu, F. Llambi, M. J. Parsons, and D. R. Green, The BCL-2 Family Reunion, Mol. Cell, vol.37, pp.299-310, 2010.

K. H. Chong, S. Samarasinghe, D. Kulasiri, and J. Zheng, Mathematical modelling of core regulatory mechanism in p53 protein that activates apoptotic switch, J. Theor. Biol, vol.462, pp.134-147, 2019.

L. Clancy, K. Mruk, K. Archer, M. Woelfel, J. Mongkolsapaya et al., Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis, Proc. Natl. Acad. Sci, vol.102, pp.18099-18104, 2005.

A. A. Cohen, N. Geva-zatorsky, E. Eden, M. Frenkel-morgenstern, I. Issaeva et al., Dynamic Proteomics of Individual Cancer Cells in Response to a Drug, Science, vol.322, pp.1511-1516, 2008.

V. Cowling and J. Downward, Caspase-6 is the direct activator of caspase-8 in the cytochrome c-induced apoptosis pathway: absolute requirement for removal of caspase-6 prodomain, Cell Death Differ, vol.9, pp.1046-1056, 2002.

J. Cui, C. Chen, H. Lu, T. Sun, and P. Shen, Two Independent Positive Feedbacks and Bistability in the Bcl-2 Apoptotic Switch, PLoS ONE, vol.3, 2008.

M. Das-thakur, F. Salangsang, A. S. Landman, W. R. Sellers, N. K. Pryer et al., Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance, Nature, vol.494, pp.251-255, 2013.

D. De-miguel, J. Lemke, A. Anel, H. Walczak, and L. Martinez-lostao, Onto better TRAILs for cancer treatment, Cell Death Differ, vol.23, pp.733-747, 2016.

M. A. Degli-esposti, W. C. Dougall, P. J. Smolak, J. Y. Waugh, C. A. Smith et al., The Novel Receptor TRAIL-R4 Induces NF-?B and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death Domain, Immunity, vol.7, pp.813-820, 1997.

Y. Deng, TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO, Genes Dev, vol.16, pp.33-45, 2002.

G. Dewson and R. M. Kluck, Mechanisms by which Bak and Bax permeabilise mitochondria during apoptosis, J. Cell Sci, vol.122, pp.2801-2808, 2009.

L. S. Dickens, R. S. Boyd, R. Jukes-jones, M. A. Hughes, G. L. Robinson et al., A Death Effector Domain Chain DISC Model Reveals a Crucial Role for Caspase-8 Chain Assembly in Mediating Apoptotic Cell Death, Mol. Cell, vol.47, pp.291-305, 2012.

H. Dueck, J. Eberwine, and J. Kim, Variation is function: Are single cell differences functionally important?: Testing the hypothesis that single cell variation is required for aggregate function, BioEssays, vol.38, pp.172-180, 2016.

F. Edlich, S. Banerjee, M. Suzuki, M. M. Cleland, D. Arnoult et al., Bcl-xL Retrotranslocates Bax from the Mitochondria into the Cytosol, Cell, vol.145, pp.104-116, 2011.

T. Eissing, H. Conzelmann, E. D. Gilles, F. Allgöwer, E. Bullinger et al., Bistability Analyses of a Caspase Activation Model for Receptor-induced Apoptosis, J. Biol. Chem, vol.279, pp.36892-36897, 2004.

N. Eling, M. D. Morgan, and J. C. Marioni, Challenges in measuring and understanding biological noise, Nat. Rev. Genet, vol.20, pp.536-548, 2019.

M. B. Elowitz, Stochastic Gene Expression in a Single Cell, Science, vol.297, pp.1183-1186, 2002.

D. A. Flusberg, J. Roux, S. L. Spencer, and P. K. Sorger, Cells surviving fractional killing by TRAIL exhibit transient but sustainable resistance and inflammatory phenotypes, Mol. Biol. Cell, vol.24, pp.2186-2200, 2013.

S. Fulda and D. Vucic, Targeting IAP proteins for therapeutic intervention in cancer, Nat. Rev. Drug Discov, vol.11, pp.109-124, 2012.

M. Fussenegger, J. E. Bailey, and J. Varner, A mathematical model of caspase function in apoptosis, Nat. Biotechnol, vol.18, pp.768-774, 2000.

L. Galluzzi, K. Blomgren, and G. Kroemer, Mitochondrial membrane permeabilization in neuronal injury, Nat. Rev. Neurosci, vol.10, pp.481-494, 2009.

S. Gaudet, S. L. Spencer, W. W. Chen, and P. K. Sorger, Exploring the Contextual Sensitivity of Factors that Determine Cell-to-Cell Variability in Receptor-Mediated Apoptosis, PLoS Comput. Biol, vol.8, 2012.

K. R. Ghusinga and A. Singh, Analysis of stochastic timing of intracellular events with gene switching (preprint), Systems Biology, 2019.

D. Gibellini, M. Borderi, E. De-crignis, R. Cicola, F. Vescini et al., RANKL/OPG/TRAIL plasma levels and bone mass loss evaluation in antiretroviral naive HIV-1-positive men, J. Med. Virol, vol.79, pp.1446-1454, 2007.

D. T. Gillespie, Exact stochastic simulation of coupled chemical reactions, J. Phys. Chem, vol.81, pp.2340-2361, 1977.

D. T. Gillespie, A general method for numerically simulating the stochastic time evolution of coupled chemical reactions, J. Comput. Phys, vol.22, pp.90041-90044, 1976.

I. Golding, J. Paulsson, S. M. Zawilski, and E. C. Cox, Real-Time Kinetics of Gene Activity in Individual Bacteria, Cell, vol.123, pp.1025-1036, 2005.

J. C. Goldstein, N. J. Waterhouse, P. Juin, G. I. Evan, and D. R. Green, The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant, Nat. Cell Biol, vol.2, pp.156-162, 2000.

L. C. Gomes-pereira, M. Chaves, and J. Roux, The role of caspase-10 in apoptosis: a positive feedback loop to explain cell response heterogeneity in a Trail-receptor model, 2020.

D. Gonze and A. Ouattara, Stochastic simulations_applications to biomolecular networks, 2014.

D. R. Green, The Pathophysiology of Mitochondrial Cell Death, Science, vol.305, pp.626-629, 2004.

A. Hantusch, M. Rehm, and T. Brunner, Counting on Death -Quantitative aspects of Bcl-2 family regulation, FEBS J, vol.285, pp.4124-4138, 2018.

C. V. Harper, B. Finkenstädt, D. J. Woodcock, S. Friedrichsen, S. Semprini et al., Dynamic Analysis of Stochastic Transcription Cycles, PLoS Biol, vol.9, 2011.

R. S. Herbst, R. Kurzrock, D. S. Hong, M. Valdivieso, C. Hsu et al., A First-in-Human Study of Conatumumab in Adult Patients with Advanced Solid Tumors, Clin. Cancer Res, vol.16, pp.5883-5891, 2010.

C. Holohan, S. Van-schaeybroeck, D. B. Longley, and P. G. Johnston, Cancer drug resistance: an evolving paradigm, Nat. Rev. Cancer, vol.13, pp.714-726, 2013.

S. Horn, M. A. Hughes, R. Schilling, C. Sticht, T. Tenev et al., Caspase-10 Negatively Regulates Caspase-8-Mediated Cell Death, Switching the Response to CD95L in Favor of NF-?B Activation and Cell Survival, Cell Rep, vol.19, pp.785-797, 2017.

C. C. Howells, W. T. Baumann, D. C. Samuels, and C. V. Finkielstein, The Bcl-2-associated death promoter (BAD) lowers the threshold at which the Bcl-2-interacting domain death agonist (BID) triggers mitochondria disintegration, J. Theor. Biol, vol.271, pp.114-123, 2011.

F. Hua, M. G. Cornejo, M. H. Cardone, C. L. Stokes, and D. A. Lauffenburger, Effects of Bcl-2 Levels on Fas Signaling-Induced Caspase-3 Activation: Molecular Genetic Tests of Computational Model Predictions, J. Immunol, vol.175, pp.985-995, 2005.

K. Huang, J. Zhang, K. L. O'neill, C. B. Gurumurthy, R. M. Quadros et al., Cleavage by Caspase 8 and Mitochondrial Membrane Association Activate the BH3-only Protein Bid during TRAIL-induced Apoptosis, J. Biol. Chem, vol.291, pp.11843-11851, 2016.

H. J. Huber, H. Duessmann, J. Wenus, S. M. Kilbride, and J. H. Prehn, Mathematical modelling of the mitochondrial apoptosis pathway, Biochim. Biophys. Acta BBA -Mol. Cell Res, vol.1813, pp.608-615, 2011.

M. A. Hughes, I. R. Powley, R. Jukes-jones, S. Horn, M. Feoktistova et al., Co-operative and Hierarchical Binding of c-FLIP and Caspase-8: A Unified Model Defines How c-FLIP Isoforms Differentially Control Cell Fate, Mol. Cell, vol.61, pp.834-849, 2016.

S. G. Hymowitz, H. W. Christinger, G. Fuh, M. Ultsch, M. O'connell et al., Triggering Cell Death. Mol. Cell, vol.4, pp.80207-80212, 1999.

K. Iwamoto, Y. Shindo, and K. Takahashi, Modeling Cellular Noise Underlying Heterogeneous Cell Responses in the Epidermal Growth Factor Signaling Pathway, PLOS Comput. Biol, vol.12, 2016.

M. D. Jacobson, M. Weil, and M. C. Raff, Programmed Cell Death in Animal Development, Cell, vol.88, pp.347-354, 1997.

E. Y. Jones, J. Mongkolsapaya, J. M. Grimes, N. Chen, X. Xu et al., , 1999.

, Nat. Struct. Biol, vol.6, pp.1048-1053

P. Juin, O. Geneste, F. Gautier, S. Depil, and M. Campone, Decoding and unlocking the BCL-2 dependency of cancer cells, Nat. Rev. Cancer, vol.13, pp.455-465, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-02481124

S. M. Kallenberger, J. Beaudouin, J. Claus, C. Fischer, P. K. Sorger et al., Intra-and Interdimeric Caspase-8 Self-Cleavage Controls Strength and Timing of CD95-Induced Apoptosis, Sci. Signal, vol.7, pp.23-23, 2014.

J. F. Kerr, A. H. Wyllie, and A. R. Currie, Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics, Br. J. Cancer, vol.26, pp.239-257, 1972.

W. Kolch, M. Halasz, M. Granovskaya, and B. N. Kholodenko, The dynamic control of signal transduction networks in cancer cells, Nat. Rev. Cancer, vol.15, pp.515-527, 2015.

E. Koz?owska and K. Puszynski, Application of bifurcation theory and siRNA-based control signal to restore the proper response of cancer cells to DNA damage, J. Theor. Biol, vol.408, pp.213-221, 2016.

A. Kreso, C. A. O'brien, P. Van-galen, O. I. Gan, F. Notta et al., Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer, Science, vol.339, pp.543-548, 2013.

A. Kretz, S. Von-karstedt, A. Hillenbrand, D. Henne-bruns, U. Knippschild et al., Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy, Cancers, vol.10, 2018.

D. Labavi?, M. T. Ladjimi, Q. Thommen, and B. Pfeuty, Scaling laws of cell-fate responses to transient stress, J. Theor. Biol, vol.478, pp.14-25, 2019.

P. Labhsetwar, J. A. Cole, E. Roberts, N. D. Price, and Z. A. Luthey-schulten, Heterogeneity in protein expression induces metabolic variability in a modeled Escherichia coli population, Proc. Natl. Acad. Sci, vol.110, pp.14006-14011, 2013.

H. N. Leblanc and A. Ashkenazi, Apo2L/TRAIL and its death and decoy receptors, Cell Death Differ, vol.10, pp.66-75, 2003.

E. E. Lederman, J. M. Hope, and M. R. King, Mass Action Kinetic Model of Apoptosis by TRAIL-Functionalized Leukocytes, Front. Oncol, vol.8, p.410, 2018.

R. E. Lee, M. A. Qasaimeh, X. Xia, D. Juncker, and S. Gaudet, NF-?B signalling and cell fate decisions in response to a short pulse of tumour necrosis factor, Sci. Rep, vol.6, p.39519, 2016.

S. Legewie, N. Blüthgen, and H. Herzel, Mathematical Modeling Identifies Inhibitors of Apoptosis as Mediators of Positive Feedback and Bistability, PLoS Comput. Biol, vol.2, issue.120, 2006.

B. Lehner and K. Kaneko, Fluctuation and response in biology, Cell. Mol. Life Sci, vol.68, pp.1005-1010, 2011.

C. Liesche, J. Berndt, F. Fricke, S. Aschenbrenner, M. Heilemann et al., CD95 receptor activation by ligand-induced trimerization is independent of its partial pre-ligand assembly (preprint), Cell Biology, 2018.

T. Lionnet and R. H. Singer, Transcription goes digital, EMBO Rep, vol.13, pp.313-321, 2012.

F. Llambi, T. Moldoveanu, S. W. Tait, L. Bouchier-hayes, J. Temirov et al., A Unified Model of Mammalian BCL-2 Protein Family Interactions at the Mitochondria, Mol. Cell, vol.44, pp.517-531, 2011.

A. Llamosi, A. M. Gonzalez-vargas, C. Versari, E. Cinquemani, G. Ferrari-trecate et al., What Population Reveals about Individual Cell Identity: Single-Cell Parameter Estimation of Models of Gene Expression in Yeast, PLOS Comput. Biol, vol.12, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01248298

R. B. Lopes, R. Gangeswaran, I. A. Mcneish, Y. Wang, and N. R. Lemoine, Expression of the IAP protein family is dysregulated in pancreatic cancer cells and is important for resistance to chemotherapy, Int. J. Cancer, vol.120, pp.2344-2352, 2007.

S. M. Mariani, B. Matiba, E. A. Armandola, and P. H. Krammer, Interleukin 1?-converting Enzyme Related Proteases/Caspases Are Involved in TRAIL-induced Apoptosis of Myeloma and Leukemia Cells, J. Cell Biol, vol.137, p.9, 1997.

S. Márquez-jurado, J. Díaz-colunga, R. P. Das-neves, A. Martinez-lorente, F. Almazán et al., Mitochondrial levels determine variability in cell death by modulating apoptotic gene expression, Nat. Commun, vol.9, 2018.

M. S. Merchant, J. I. Geller, K. Baird, A. J. Chou, S. Galli et al., Phase I Trial and Pharmacokinetic Study of Lexatumumab in Pediatric Patients With Solid Tumors, J. Clin. Oncol, vol.30, pp.4141-4147, 2012.

H. Miura, Y. Kondo, M. Matsuda, and K. Aoki, Cell-to-Cell Heterogeneity in p38-Mediated Cross-Inhibition of JNK Causes Stochastic Cell Death, Cell Rep, vol.24, pp.2658-2668, 2018.

M. Mori, T. Hwa, O. C. Martin, A. De-martino, and E. Marinari, Constrained Allocation Flux Balance Analysis, PLOS Comput. Biol, vol.12, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02636532

P. A. Muller and K. H. Vousden, p53 mutations in cancer, Nat. Cell Biol, vol.15, issue.2-8, 2013.

S. Neumann, J. Hasenauer, N. Pollak, and P. Scheurich, Dominant Negative Effects of Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL) Receptor 4 on TRAIL Receptor 1 Signaling by Formation of Heteromeric Complexes, J. Biol. Chem, vol.289, pp.16576-16587, 2014.

J. R. Newman, S. Ghaemmaghami, J. Ihmels, D. K. Breslow, M. Noble et al., Single-cell proteomic analysis of S. cerevisiae reveals the architecture of biological noise, Nature, vol.441, pp.840-846, 2006.

M. Olivier, M. Hollstein, and P. Hainaut, TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use, Cold Spring Harb. Perspect. Biol, vol.2, pp.1008-001008, 2010.

E. M. Ozbudak, M. Thattai, I. Kurtser, A. D. Grossman, and A. Van-oudenaarden, Regulation of noise in the expression of a single gene, Nat. Genet, vol.31, pp.69-73, 2002.

A. L. Paek, J. C. Liu, A. Loewer, W. C. Forrester, and G. Lahav, Cell-to-Cell Variation in p53 Dynamics Leads to Fractional Killing, Cell, vol.165, pp.631-642, 2016.

B. Pennarun, A. Meijer, E. G. De-vries, J. H. Kleibeuker, F. Kruyt et al., Playing the DISC: Turning on TRAIL death receptor-mediated apoptosis in cancer, Biochim. Biophys. Acta BBA -Rev. Cancer, vol.1805, pp.123-140, 2010.

E. Pujadas and A. P. Feinberg, Regulated Noise in the Epigenetic Landscape of Development and Disease, Cell, vol.148, pp.1123-1131, 2012.

H. Qi and J. Shuai, Alzheimer's disease via enhanced calcium signaling caused by the decrease of endoplasmic reticulum-mitochondrial distance, Med. Hypotheses, vol.89, pp.28-31, 2016.

A. Safa, Roles of c-FLIP in Apoptosis, Necroptosis, and Autophagy, J. Carcinog. Mutagen, 2013.

A. Raj, C. S. Peskin, D. Tranchina, D. Y. Vargas, and S. Tyagi, Stochastic mRNA Synthesis in Mammalian Cells, PLoS Biol, vol.4, 2006.

A. Raj and A. Van-oudenaarden, Nature, Nurture, or Chance: Stochastic Gene Expression and Its Consequences, Cell, vol.135, pp.216-226, 2008.

J. M. Raser, Control of Stochasticity in Eukaryotic Gene Expression, Science, vol.304, pp.1811-1814, 2004.

M. Rehm, H. Düßmann, R. U. Jänicke, J. M. Tavaré, D. Kögel et al., Single-cell Fluorescence Resonance Energy Transfer Analysis Demonstrates That Caspase Activation during Apoptosis Is a Rapid Process: ROLE OF CASPASE-3, J. Biol. Chem, vol.277, pp.24506-24514, 2002.

M. Rehm, H. J. Huber, H. Dussmann, and J. H. Prehn, Systems analysis of effector caspase activation and its control by X-linked inhibitor of apoptosis protein, EMBO J, vol.25, pp.4338-4349, 2006.

M. Rehm, H. J. Huber, C. T. Hellwig, S. Anguissola, H. Dussmann et al., Dynamics of outer mitochondrial membrane permeabilization during apoptosis, Cell Death Differ, vol.16, pp.613-623, 2009.

T. T. Renault and J. E. Chipuk, Death upon a Kiss: Mitochondrial Outer Membrane Composition and Organelle Communication Govern Sensitivity to BAK/BAX-Dependent Apoptosis, Chem. Biol, vol.21, pp.114-123, 2014.

S. J. Riedl and G. S. Salvesen, The apoptosome: signalling platform of cell death, Nat. Rev. Mol. Cell Biol, vol.8, pp.405-413, 2007.

N. J. Roberts, S. Zhou, L. A. Diaz, and M. Holdhoff, Systemic use of tumor necrosis factor alpha as an anticancer agent, Oncotarget, vol.2, 2011.

C. M. Rocha-lima, S. Bayraktar, A. M. Flores, J. Macintyre, A. Montero et al., Phase Ib Study of Drozitumab Combined With First-Line mFOLFOX6 Plus Bevacizumab in Patients with Metastatic Colorectal Cancer, Cancer Invest, vol.30, pp.727-731, 2012.

A. Roesch, M. Fukunaga-kalabis, E. C. Schmidt, S. E. Zabierowski, P. A. Brafford et al., A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth, Cell, vol.141, pp.583-594, 2010.

J. Roux, M. Hafner, S. Bandara, J. J. Sims, H. Hudson et al., Fractional killing arises from cell-to-cell variability in overcoming a caspase activity threshold, Mol. Syst. Biol, vol.11, 2015.

K. A. Sarosiek, T. Ni-chonghaile, and A. Letai, Mitochondria: gatekeepers of response to chemotherapy, Trends Cell Biol, vol.23, pp.612-619, 2013.

B. Schellenberg, P. Wang, J. A. Keeble, R. Rodriguez-enriquez, S. Walker et al., Bax Exists in a Dynamic Equilibrium between the Cytosol and Mitochondria to Control Apoptotic Priming, Mol. Cell, vol.49, pp.959-971, 2013.

R. Schlatter, K. Schmich, I. Avalos-vizcarra, P. Scheurich, T. Sauter et al., ON/OFF and Beyond -A Boolean Model of Apoptosis, PLoS Comput. Biol, vol.5, 2009.

K. Schleich, J. H. Buchbinder, S. Pietkiewicz, T. Kähne, U. Warnken et al., Molecular architecture of the DED chains at the DISC: regulation of procaspase-8 activation by short DED proteins c-FLIP and procaspase-8 prodomain, Cell Death Differ, vol.23, pp.681-694, 2016.

P. Schneider, M. Thome, K. Burns, J. Bodmer, K. Hofmann et al., TRAIL Receptors 1 (DR4) and 2 (DR5) Signal FADD-Dependent Apoptosis and Activate NF-?B, Immunity, vol.7, issue.00, p.80401, 1997.

N. E. Scott, L. D. Rogers, A. Prudova, N. F. Brown, N. Fortelny et al., Interactome disassembly during apoptosis occurs independent of caspase cleavage, Mol. Syst. Biol, vol.13, p.906, 2017.

S. Sharma, E. G. De-vries, J. R. Infante, C. N. Oldenhuis, J. A. Gietema et al., Safety, pharmacokinetics, and pharmacodynamics of the DR5 antibody LBY135 alone and in combination with capecitabine in patients with advanced solid tumors, Invest. New Drugs, vol.32, pp.135-144, 2014.

S. V. Sharma, D. Y. Lee, B. Li, M. P. Quinlan, F. Takahashi et al., A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations, Cell, vol.141, pp.69-80, 2010.

M. S. Sherman, K. Lorenz, M. H. Lanier, and B. A. Cohen, Cell-to-Cell Variability in the Propensity to Transcribe Explains Correlated Fluctuations in Gene Expression, Cell Syst, vol.1, pp.315-325, 2015.

Y. Shlyakhtina, V. Pavet, and H. Gronemeyer, Dual role of DR5 in death and survival signaling leads to TRAIL resistance in cancer cells, Cell Death Dis, vol.8, pp.3025-3025, 2017.

A. Sigal, R. Milo, A. Cohen, N. Geva-zatorsky, Y. Klein et al., Variability and memory of protein levels in human cells, Nature, vol.444, pp.643-646, 2006.

D. Sohn, K. Schulze-osthoff, and R. U. Jänicke, Caspase-8 Can Be Activated by Interchain Proteolysis without Receptor-triggered Dimerization during Drug-induced Apoptosis, J. Biol. Chem, vol.280, pp.5267-5273, 2005.

S. L. Spencer, S. Gaudet, J. G. Albeck, J. M. Burke, and P. K. Sorger, Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis, Nature, vol.459, pp.428-432, 2009.

J. Stewart-ornstein, J. S. Weissman, and H. El-samad, Cellular Noise Regulons Underlie Fluctuations in Saccharomyces cerevisiae, Mol. Cell, vol.45, pp.483-493, 2012.

S. Stoma, A. Donzé, F. Bertaux, O. Maler, and G. Batt, STL-based Analysis of TRAILinduced Apoptosis Challenges the Notion of Type I/Type II Cell Line Classification, PLoS Comput. Biol, vol.9, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00926593

J. W. Stucki and H. Simon, Mathematical modeling of the regulation of caspase-3 activation and degradation, J. Theor. Biol, vol.234, pp.123-131, 2005.

D. M. Suter, N. Molina, D. Gatfield, K. Schneider, U. Schibler et al., Mammalian Genes Are Transcribed with Widely Different Bursting Kinetics, Science, vol.332, pp.472-474, 2011.

Y. Suzuki, Y. Nakabayashi, and R. Takahashi, Ubiquitin-protein ligase activity of Xlinked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death, Proc. Natl. Acad. Sci, vol.98, pp.8662-8667, 2001.

J. S. Swers, L. Grinberg, L. Wang, H. Feng, K. Lekstrom et al., Multivalent Scaffold Proteins as Superagonists of TRAIL Receptor 2-Induced Apoptosis, Mol. Cancer Ther, vol.12, pp.1235-1244, 2013.

E. Szegezdi, A. M. Van-der-sloot, D. Mahalingam, L. O'leary, R. H. Cool et al., Kinetics in Signal Transduction Pathways Involving Promiscuous Oligomerizing Receptors Can Be Determined by Receptor Specificity: Apoptosis Induction by TRAIL, Mol. Cell. Proteomics, vol.11, 2012.

S. W. Tait and D. R. Green, Mitochondria and cell death: outer membrane permeabilization and beyond, Nat. Rev. Mol. Cell Biol, vol.11, pp.621-632, 2010.

C. Tan, P. J. Dlugosz, J. Peng, Z. Zhang, S. M. Lapolla et al., Auto-activation of the Apoptosis Protein Bax Increases Mitochondrial Membrane Permeability and Is Inhibited by Bcl-2, J. Biol. Chem, vol.281, pp.14764-14775, 2006.

M. Thome, P. Schneider, K. Hofmann, H. Fickenscher, E. Meinl et al., Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors, Nature, vol.386, pp.517-521, 1997.

F. Todt, Z. Cakir, F. Reichenbach, F. Emschermann, J. Lauterwasser et al., Differential retrotranslocation of mitochondrial Bax and Bak, EMBO J, vol.34, pp.67-80, 2015.

S. E. Tran, T. H. Holmström, M. Ahonen, V. Kähäri, and J. E. Eriksson, MAPK/ERK Overrides the Apoptotic Signaling from Fas, TNF, and TRAIL Receptors, J. Biol. Chem, vol.276, pp.16484-16490, 2001.

A. Trauzold, H. Wermann, A. Arlt, S. Schütze, H. Schäfer et al., CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-?B contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells, Oncogene, vol.20, pp.4258-4269, 2001.

. Wajant, Molecular Mode of Action of TRAIL Receptor Agonists-Common Principles and Their Translational Exploitation, Cancers, vol.11, 2019.

Y. Wakamoto, N. Dhar, R. Chait, K. Schneider, F. Signorino-gelo et al., Dynamic Persistence of Antibiotic-Stressed Mycobacteria, Science, vol.339, pp.91-95, 2013.

H. Walczak, R. E. Miller, K. Ariail, B. Gliniak, T. S. Griffith et al., Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo, Nat. Med, vol.5, pp.157-163, 1999.

S. N. Willis, Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins, Genes Dev, vol.19, pp.1294-1305, 2005.

M. L. Würstle, E. Zink, J. H. Prehn, and M. Rehm, From computational modelling of the intrinsic apoptosis pathway to a systems-based analysis of chemotherapy resistance: achievements, perspectives and challenges in systems medicine, Cell Death Dis, vol.5, pp.1258-1258, 2014.

J. Xu, J. Zhou, W. Wei, and G. S. Wu, Activation of the Akt Survival Pathway Contributes to TRAIL Resistance in Cancer Cells, PLoS ONE, vol.5, 2010.

Z. Yin, H. Qi, L. Liu, and Z. Jin, The optimal regulation mode of Bcl-2 apoptotic switch revealed by bistability analysis, Biosystems, vol.162, pp.44-52, 2017.

A. Younes, J. M. Vose, A. D. Zelenetz, M. R. Smith, H. A. Burris et al., A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma, Br. J. Cancer, vol.103, pp.1783-1787, 2010.

T. Zhang, P. Brazhnik, and J. J. Tyson, Computational Analysis of Dynamical Responses to the Intrinsic Pathway of Programmed Cell Death, Biophys. J, vol.97, pp.415-434, 2009.

X. D. Zhang, A. V. Franco, T. Nguyen, C. P. Gray, and P. Hersey, Differential Localization and Regulation of Death and Decoy Receptors for TNF-Related Apoptosis-Inducing Ligand (TRAIL) in Human Melanoma Cells, J. Immunol, vol.164, pp.3961-3970, 2000.

?. ?. ????????? and O. F. Voropaeva, Deregulation of p53-dependent microRNAs: the results of mathematical modeling, ?????????????? ???????? ? ??????????????, vol.12, pp.151-175, 2017.